{
    "organizations": [],
    "uuid": "eb32d33bbafe5829b0d8a6fe4db31555eb4652b3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-innovaderma-expects-h2-pre-tax-pro/brief-innovaderma-expects-h2-pre-tax-profit-to-be-similar-to-fy17-idUSFWN1QQ0HK",
    "ord_in_thread": 0,
    "title": "BRIEF-Innovaderma Expects H2 Pre-Tax Profit To Be Similar To FY17",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - Innovaderma Plc:\n* ‍CONTINUES TO EXPECT SECOND HALF YEAR TO OUTPERFORM FIRST HALF SIGNIFICANTLY​\n* ‍GROUP EXPECTS H2 REVENUES TO BE SUBSTANTIALLY HIGHER THAN LAST YEAR​\n* ‍REVENUE GROWTH FOR YEAR WILL NOW BE LESS THAN ANTICIPATED AT TIME OF INTERIM RESULTS​\n* H2 ‍PROFIT BEFORE TAX IS NOW EXPECTED TO BE SIMILAR TO FY17 DUE TO SIGNIFICANT INVESTMENT MADE ACROSS BUSINESS OVER LAST SIX MONTHS​ Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-08T18:21:00.000+02:00",
    "crawled": "2018-03-09T14:14:58.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "innovaderma",
        "plc",
        "expect",
        "second",
        "half",
        "year",
        "outperform",
        "first",
        "half",
        "expects",
        "h2",
        "revenue",
        "substantially",
        "higher",
        "last",
        "growth",
        "year",
        "less",
        "anticipated",
        "time",
        "interim",
        "h2",
        "tax",
        "expected",
        "similar",
        "fy17",
        "due",
        "significant",
        "investment",
        "made",
        "across",
        "business",
        "last",
        "six",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}